Mary Rozenman’s Post

"Excited to announce that I'm embarking on a new chapter in my career journey! 🚀 Thrilled to join Hemogenomics as Field Service Engineer. Looking forward to contributing my skills and expertise to the team and making meaningful impact. Grateful for the opportunities ahead and excited to connect with new colleagues and collaborators. Let's do great things together! #NewBeginnings #CareerMove"

This was my previous submission to ELRIG's Impact Award (Drug Discovery 2023) – spoiler alert: I wasn’t chosen, but it gave me opportunity to look into my past career and reflect on my achievements. Also, it had been a while since I had updated my CV! I have a passion for affinity. I first encountered affinity in the protein purification field as an undergraduate, but soon discovered its power in many different areas. Through the years I broaden my scientific knowledge and contributed with 9 first-author articles to the affinity ligand research. For the past 4 years I applied my expertise in affinity to the drug discovery industry. Although it’s known to be a long game, my goal is to develop molecules that can one day make someone’s life better. I have had the opportunity to contribute to many challenging discovery projects and deliver on high value projects to external collaborators. This includes molecules that will be entering Phase I clinical trials at the beginning of 2024. I learned how to apply affinity towards people and teams. Working in a CRO environment can be ruthless due to tight timelines and high expectations. Currently, as Alliances Manager of Isogenica Limited and proud leader of a small team of 5 hard-working individuals, I believe in values and personal growth to upskill and engage. This has allowed us to deliver on impactful discovery campaigns. My affinity towards personal relationships and growth has made me the person with the most reports in the company. I use creativity and problem-solving to address challenging drug discovery projects and develop molecules fit for purpose. I am an expert generalist, drawing on my knowledge from different areas to help better understand clients’ needs. My focus on collaborative relationships, affinity and high work standards has led past partners come back to my team after they have moved to new organisations. My main goal now is to explore collaborative approaches to meet the partners’ requirements by leveraging affinity between their needs and our workflow. As I develop my career, I want to influence and contribute to the new wave of drug discovery scientists that know how to grow and grow others, fostering transparency and collaboration in the industry. #affinity #alliances #relationship #team #Isogenica

https://lnkd.in/eNAUgSZr 🎉 Join us at the Orbit Annual User Conference  🎉 🤝 Connect and Network: Elevate your industry connections by engaging with like-minded peers in the life science realm. Share insights, ideas, and experiences that will shape the future of your field. 🚀 Learn from the Best: Gain invaluable knowledge as you hear directly from the brilliant minds behind Orbit. Our software experts will deep-dive into its functionalities, giving you a front-row seat to the innovation driving your success. 🌟 Real Stories, Real Impact: Witness firsthand accounts from our esteemed customers who have transformed their processes and achieved remarkable results with Orbit. Discover how this powerful tool is changing the game in the life sciences landscape. Don't miss out on this opportunity to revolutionize your approach. Register now (free) https://lnkd.in/eNAUgSZr Secure your spot today! #OrbitUserConference #LifeSciences #Innovation #Networking #Philadelphia #Pharmacovigilance

Begin and become with BioTalent. 🧬 🧪 For more than just a life sciences job, we nurture you, the change-makers, to match you with opportunities to make the greatest impact. 🌎 Visit our website to learn more: https://lnkd.in/eztfC5sX #NurturingChangemakers #BeginBecomeBetter

Now accepting! Upcoming special issue entitled "(Multi)Omics approaches in atherosclerosis", in Vascular Pharmacology (Elsevier) accepts new research articles on (multi)omics approaches in atherosclerosis. The special issue is organized by the AtheroNET consortium (#COSTActionCA21153 - #COST). COST Action AtheroNET is a Network for implementing multiomic approaches in atherosclerotic cardiovascular disease prevention and research. Manuscripts as an original work, review, or opinion paper are due by 30.6.2024. For full special issue scope: https://lnkd.in/ekUKtRgi or or contact one of the guest editors Miron Sopic, Tijana Mitić, Judith Sluimer or Yvan Devaux There will be a fast peer-review and publication process for this special issue. The journal supports both open-access and subscription articles, so you can choose what is best for you. Vascular Pharmacology already has an Impact Factor of 4 and a CiteScore of 9.2. We hope you will consider contributing to the success of this special issue by submitting an article.

Dive into our latest blog, "An MCEDC Life Sciences Industry Overview," and explore how Morris County has evolved into a nationally acclaimed epicenter for innovation and opportunity in life sciences. Uncover impressive data and notable achievements showcasing Morris County's vibrant ecosystem, attracting professionals and companies to its thriving hub. Read here!

What has your life science career trajectory looked like? It's not one size fits all. Bracken Senior Partner Ina Margaretha Rijnhout offers insights on her own career path. Learn about the necessity for lasting business partnerships, her passion for helping patients, the crucial intersection of leveraging capital for success, and more. Read the blog post here: https://lnkd.in/gZ_K2qxN #BusinessDevelopment #BiopharmaInvesting #DueDiligence #LifeSci #Bracken

What has your life science career trajectory looked like? It's not one size fits all. Bracken Senior Partner Ina Margaretha Rijnhout offers insights on her own career path. Learn about the necessity for lasting business partnerships, her passion for helping patients, the crucial intersection of leveraging capital for success, and more. Read the blog post here: https://lnkd.in/e2Mmwwk2 #BusinessDevelopment #BiopharmaInvesting #DueDiligence #LifeSci #Bracken

What has your life science career trajectory looked like? It's not one size fits all. Bracken Senior Partner Ina Margaretha Rijnhout offers insights on her own career path. Learn about the necessity for lasting business partnerships, her passion for helping patients, the crucial intersection of leveraging capital for success, and more. Read the blog post here: https://lnkd.in/dDk8FXtK #BusinessDevelopment #BiopharmaInvesting #DueDiligence #LifeSci #Bracken

In addition to the date's below I will be in Boston on the 7th and 8th and available to discuss this amazing opportunity. This is some of the most important and exciting science out there, at the cross section of AI/LLMs, NLP and Knowledge Graphs. #ai #llms #kgs